By Steven ReinbergHealthDay Reporter
WEDNESDAY, July 8, 2015 (HealthDay News) — Preliminary trial results suggest that an experimental psoriasis drug may control the chronic skin disease better than the current standard treatment.
The drug, guselkumab, was compared to the commonly used medication adalimumab (Humira, Enbrel) in a study involving nearly 300 patients with plaque psoriasis.
Up to 86 […]
Previous Psoriasis Stories
- 09/13/2013 - Psoriasis